Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
InChi: InChI=1S/C21H22O9/c22-6-8-4-10-14(21-20(29)19(28)17(26)13(7-23)30-21)9-2-1-3-11(24)15(9)18(27)16(10)12(25)5-8/h1-5
Formula: C82H107N5O20
In agreement with the in vitro study
ARB) used in the management of hypertension
(Z)-5-bromo-3-(3-bromo-4
Apatinib Catalog No.:M10435-10 InChi: InChI=1S/C21H22O9/c22-6-8-4-10-14(21-20(29)19(28)17(26)13(7-23)30-21)9-2-1-3-11(24)15(9)18(27)16(10)12(25)5-8/h1-5Apatinib, also known as Rivoceranib, is an orally bioavailable, small molecule receptor tyrosine kinase inhibitor with potential antiangiogenic and antineoplastic activities. The free base form is also known as Rivoceranib. Apatinib selectively binds to and inhibits vascular endothelial growth factor receptor 2, which may inhibit VEGF stimulated endothelial cell migration and proliferation and decrease tumor microvessel density. In addition, this